Introduction
Sequential activation of the atria and ventricles, required for efficient heart function, is made possible by the annulus fibrosis, an electrically inert structure that separates the atria and ventricles. Defects in the annulus fibrosis, bridged by threads of cardiac muscle, permit abnormal premature activation of the ventricles and predispose to atrioventricular (AV) reciprocating tachyarrhythmias , as seen in the Wolff-Parkinson-White (WPW) syndrome (Becker et al., 1978) . Improved understanding of embryological mechanisms that underlie development of the annulus fibrosis will therefore be important to understand the etiology of abnormal accessory AV connections.
The heart initially forms as a tube of two concentric layers, the endocardium and the myocardium (Buckingham et al., 2005) . Cardiac morphogenesis requires that the heart tube receive contributions from other cell populations that initially reside outside the developing heart. One important extracardiac cell population originates from the proepicardium, an outgrowth of the septum transversum (Gittenberger-de Groot et al., 1998; Perez-Pomares et al., 2002) . Cells from the proepicardium migrate to form an epithelial sheet over the surface of the heart, the epicardium. A subset of epicardial cells undergoes an epithelial-to-mesenchymal transition (EMT) to become epicardium-derived cells (EPDCs). EPDCs migrate into the underlying myocardium and have been described to differentiate into smooth muscle, endothelial, and fibroblast lineages (Gittenberger-de Groot et al., 1998; Merki et al., 2005; Wilm et al., 2005; Cai et al., 2008; Zhou et al., 2008a ). In addition, recent studies indicated that EPDCs also differentiate into cardiomyocytes (Cai et al., 2008; Zhou et al., 2008a) .
Using quail-chicken chimeras, Gittenberger-de Groot et al. showed that EPDCs are present in the annulus fibrosis and express periostin and collagen III (Gittenberger-de Groot et al., 1998; Lie-Venema et al., 2008) . Recent pioneering work by their group showed that block of EPDC migration in avian embryos resulted in abnormal annulus fibrosis formation in which abnormal muscle bundles (accessory pathways) bridged from atria to ventricles. This provided the anatomical substrate for abnormal electrical impulse conduction analogous to that seen in WPW (Kolditz et al., 2007; Kolditz et al., 2008) . These studies of avian embryos were the first to reveal the embryological origins that may underlie development of accessory pathways, thus raising interest in epicardium and EPDCs in relation to defective annulus fibrosis formation.
The role of epicardium and EPDCs in the formation of the mammalian annulus fibrosis and the process of migration and cellular transition have not been described. To investigate these questions, we used a Cre-LoxP approach (Soriano, 1999) to genetically trace the fate of EPDCs in the annulus fibrosis of the developing mouse heart. We provide definitive evidence that EPDCs differentiate into fibroblasts that synthesize components of the annulus fibrosis during mammalian heart development. We also identify altered expression of key components of the EMT gene program that likely contribute to formation and differentiation of annulus EPDCs.
Materials and methods

Mice
Wt1
CreERT2/+ mice were generated by gene targeting followed by
Flp-mediated removal of a Neo resistance cassette, as described previously (Zhou et al., 2008a) . CreERT2 is a fusion protein composed of Cre recombinase and a modified variant of the estrogen receptor hormone binding domain. CreERT2 recombines floxed targets in the presence, but not the absence of tamoxifen (Feil et al., 1997) . We injected 2 mg of tamoxifen (Sigma) intraperitoneally to pregnant mice at E10.5 to induce Cre activity. Rosa26 fsLz (Soriano, 1999) and Rosa26 mTmG (Muzumdar et al., 2007) mice were used as Credependent reporters. These mice express LacZ and membranelocalized GFP, respectively, after Cre-mediated recombination. Pregnancies were dated by daily inspection for a vaginal plug. Noon of the day of the plug was defined as E0.5. All mice were used according to protocols approved by the Institutional Animal Care and Use Committee at Children's Hospital Boston.
Histology
Embryos were collected in PBS on ice and then fixed in 4% PFA at 4°C for 4 hours. After washing in PBS, tissues were treated in 15% and 30% sucrose for 2 hours each and embedded in OCT. About 5-8 μm cryostat sections were collected on positively charged slides. X-gal staining was performed first by incubating with 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal; 1 mg/ml) at 37°C overnight as previously described (Zhou et al., 2008b) . X-gal-stained sections were then washed in PBS, blocked in 5% serum/PBS, and subjected to immunostaining. Antibody sources were as follows: β-galactosidase (β-gal), MP Biochemicals; Desmin, Santa Cruz; Periostin, Abcam; procollagen I, Millipore; GFP, Invitrogen. Antibody staining was visualized by standard indirect immunofluorescence, by the ABC method (Vector Labs), or by tyramide amplification (Perkin-Elmer). Vector SG (gray; Vector Labs) and Permanent Red (Dako) were used for chromogenic detection. Fluorescently stained slides were counterstained with DAPI and imaged with an FV1000 confocal microscope (Olympus). Images shown are representative of findings in a minimum of three independent embryos.
Tissue dissociation and cell sorting
The atrioventricular canal or apical regions of hearts embryonic hearts were isolated by microdissection and dissociated to single cells by collagenase digestion as previously described (Zhou et al., 2008a) . In EPDC isolations, tissue from 2 to 3 embryos was pooled into one sample. Isolated cells were FACS sorted into GFP + and GFP -populations. Sorted cells were collected into Trizol (Invitrogen) and frozen at − 20°C. On average, we obtained 5000-6000 GFP + cells per atrioventricular region of an E14.5 or E15.5 heart.
Gene expression analysis
RNA was prepared using the standard Trizol protocol followed by the RNeasy kit with on-column DNase digestion (Qiagen) as previously described (Zhou et al., 2009) . Quantitative real-time RT-PCR was performed on an ABI 7300 Sequence Detector (Applied Biosystems) using TaqMan (Gapdh) or Sybr Green (Myh6, Postn, Col1a1, Vimentin, Ddr2, Tnc, Fn1, Slug, Snail, Smad1, Twist1, Mmp2, Scn5a, Gja1) detection methods. See Table 1 for primer sequences. Five to eight samples were used per group.
Statistics
All results are expressed as mean ± SEM. Statistical significance was evaluated by Welch's t-test, using JMP software, version 5.1. P values less than 0.05 were considered to be statistically significant.
Results
To delineate the cellular contribution of epicardial-derived cells to the annulus fibrosis, we used a Cre-LoxP approach (Soriano, 1999) to genetically label epicardial cells and their descendants. We used an inducible Cre recombinase (CreERT2) (Feil et al., 1997) driven by Wilm's tumor 1 (Wt1) regulatory elements (Zhou et al., 2008a) . The CreERT2 protein, composed of Cre recombinase fused to a modified domain of the estrogen receptor (ESR1), can be detected by ESR1-specific antibody. In control experiments, we showed that hearts of wild-type embryos lack ESR1 immunoreactivity (Suppl. Figs. 1A and B and data not shown). In hearts of E10.5-E16.5 Wt1
CreERT2/+ embryos, we found that CreERT2 expression was confined to the epicardium (Figs. 1A-C), consistent with our previous studies (Zhou et al., 2008a,b) . CreERT2-expressing cells were also observed in the dorsal mesocardium and the posterior heart field surrounding the cardinal veins (Fig. 1A) .
To induce Cre activity and pulse-label Wt1 + epicardial cells, we administered a single dose of the CreERT2 activating agent, tamoxifen (Tam), to gravid females at E10.5. In the absence of Tam treatment, we did not detect activation of the Cre-dependent reporter Rosa26 fsLz (Suppl. Fig. 1C ). Tam treatment of Wt1 CreERT2/+ embryos resulted in irrevocable and heritable Cre-mediated activation of β-galactosidase (β-gal) expression from Rosa26 fsLz (Fig. 1D ). Epicardium-derived cells could then be identified by expression of the β-gal lineage tracer, even without continued Cre expression. In the E15.5 atrioventricular (AV) junction, we used immunostaining to detect β-gal + EPDCs within the Table 1 Primers used for qRT-PCR assays in this study.
Detected with a Taqman TaqMan-based assay (Applied Biosystems) myocardium (Fig. 1E ). To minimize potential artifacts from immunostaining, we also used X-gal staining for enzymatic β-galactosidase activity as an independent method to identify β-gal + EPDCs (Figs. 1F and G). By both methods, EPDCs were located throughout the myocardium. At the atrioventricular junction, EPDCs were located between atrial and ventricular myocardium (Figs. 1F and G) . To evaluate the location of EPDCs relative to the developing annulus fibrosis, we performed costaining for periostin, an extracellular matrix protein strongly expressed in the annulus fibrosis and other collagenrich fibrous connective tissues (Kruzynska-Frejtag et al., 2001; Kern et al., 2005; Kolditz et al., 2008) . At E15.5, the periostin-positive developing annulus fibrosis was located at the atrioventricular junction and incompletely separated atrial and ventricular myocardium. Most of the migrating EPDCs in the AV junction were localized to periostin positive regions, indicating their presence within the annulus fibrosis (Figs. 1E-G, arrows). However, not all labelled EPDCs were periostinpositive (Fig. 1E , insert 2, white arrowhead). In addition, EPDC expression of periostin was largely restricted to the annulus, suggesting that local signals regulate EPDC periostin production (Figs. 1E-G and 2). There were also periostin-rich regions that contained scant EPDCs, such as the AV valve leaflets, indicating that cell types in the AV canal region other than EPDCs also synthesize periostin. Because the readout of Cre recombination can vary depending on the reporter allele (Vooijs et al., 2001; Ma et al., 2008) , we used an independent Cre-activated reporter allele, Rosa26mTmG (Muzumdar et al., 2007) to provide additional support for our finding that EPDCs migrate into the annulus fibrosis. Before Cre recombination, the Rosa26 mTmG allele ubiquitously expresses membrane-localized red fluorescent protein (RFP). After Cre recombination, it expresses membrane-localized GFP. We generated Wt1
CreERT2/+ ;Rosa26 mTmG/+ embryos and initiated the lineage trace by injecting tamoxifen at E10.5 ( Fig. 2A) . At E15.5, GFP-expressing EPDCs were found within the periostin + annulus fibrosis (Figs. 2B-D) , confirming the Rosa26 fsLz lineage trace data (Fig. 1) . We also observed a small number of EPDCs within endocardial cushion-derived structures (Fig. 2D) , as described in chick models (Gittenberger-de Groot et al., 1998). We followed the fate of EPDCs through further stages of development of the annulus fibrosis. At E16.5 and E17.5 (Figs. 3 and 4) , periostin staining at the atrioventricular junction more completely separated atrial and ventricular myocardium. Unlike avian embryos , periostin was not robustly detectable in most epicardial β-gal-positive cells, indicating that murine epicardial progenitors of EPDCs not express periostin (Fig. 3C, white arrowheads) . Subepicardial EPDCs that had undergone EMT were likewise periostin-negative (Figs. 2B and 3C ). In contrast, migrating EPDCs that penetrated the myocardium at the atrioventricular junction became bounded by periostin-containing extracellular matrix (arrows, Figs. 3B and 4A), suggesting that local signals confined to this region stimulate a subset of EPDCs to express periostin. We independently confirmed the above results by X-gal staining and immunohistochemistry (Figs. 4B and C). Our previous work showed that a subset of EPDCs migrate into myocardium and differentiate into cardiomyocytes (Zhou et al., 2008a) . The EPDCs in the annulus fibrosis were negative for cardiomyocytes markers (Desmin, TNNT2; Figs. 3D and 4C), suggesting that EPDCs at the atrioventricular junction largely did not commit to a cardiomyocyte fate. Our data indicated that EPDCs are present within the annulus fibrosis. However, because periostin protein is present both intra-and extracellularly , coimmunostaining with periostin did not provide clear evidence to show that these cells directly contribute to the synthesis of extracellular matrix components of the annulus. To investigate this question, we used the fibroblast marker procollagen I (COL1A1), a precursor of collagen I largely present within cells. Many epicardial cells expressed procollagen I (Fig. 5A , white arrowheads). However, most EPDCs no longer expressed this marker (Fig. 5B, blue arrowheads) , suggesting that it is downregulated upon transition to mesenchymal cells. Cells at the atrioventricular junction coexpressed procollagen I and the β-gal lineage tracer (Figs. 5B and C, white arrows), indicating that EPDCs in this region differentiated into fibroblasts and reexpressed procollagen I, contributing to the collagen I content of the annulus fibrosis. As with periostin, EPDCs in the annulus fibrosis, but not within the myocardium, expressed procollagen I. Restriction of EPDC expression of periostin and procollagen I to the annulus fibrosis suggests that local signals in the atrioventricular junction region stimulate EPDC differentiation into cells that produce annulus fibrosis components.
To further delineate the pattern of gene expression in EPDCs at the atrioventricular junction, we treated E10. Fig. 2 ), suggesting that the sorting was effective in separating EPDCs from non-EPDCs. This was confirmed by similar measurements at E15.5 and E16.5 (data not shown). Interestingly, expression of the gap junction gene connexin 43 (Gja1) was upregulated in EPDCs compared to non-EPDCs (Suppl. Fig. 2 ). Gja1 expression in epicardium and proepicardium has been noted previously (Li et al., 2002) . GFP + EPDCs were highly enriched for mesenchymal/fibroblast markers vimentin (vim) and discoidin domain containing receptor 2 (Ddr2) and tenascin C (Tnc), fibronectin 1 (Fn1), as well as for transcripts encoding the annulus fibrosis components periostin (Postn), and procollagen I (Col1a1) (Fig. 6C) . Because the qRT-PCR assay detects mRNA transcripts rather than potentially secreted protein products, these data providing direct evidence that EPDCs express extracellular matrix components of the annulus fibrosis. Smad1, Slug, Snail, and Twist1, transcription factors that regulate EMT in other contexts (Mani et al., 2008) , were also significantly upregulated in GFP + EPDCs (Fig. 6D) , consistent with active formation of EPDCs from atrioventricular junction epicardium via EMT and implicating these factors in the regulation of EPDC EMT. Matrix metalloprotease 2 (Mmp2), which degrades extracellular matrix and promotes cellular migration, were also upregulated in EPDCs (Fig. 6E) , suggesting that migrating EPDCs secrete proteins to facilitate their own migration. The fibrosis markers (Postn, Col1a1, Fn1), mesenchymal markers (Vim, Ddr2, Tnc), EMT transcripts (Smad1, Snail, Slug, GFPCre/+ hearts, GFP expression was restricted to the epicardium and is coexpressed with the epicardial marker WT1 (Fig. 7A ) (Zhou et al., 2008a (Fig. 7B ). Col1a1 was highly upregulated in both populations. The patterns of Col1a1 and Postn expression were consistent with immunohistochemistry (Figs. 1E and 5A). Among transcriptional regulators of EMT, Snail and Twist1 were not upregulated in epicardial cells (Fig. 7B ). Smad1 and Slug were upregulated in epicardial cells (Fig. 7B) but to a substantially lower degree compared with AF EPDCs (Figs. 6C and F) . Mmp2 was also slightly upregulated in epicardial cells, but again, the degree of enrichment was less than observed in migrating EPDCs. GFPCre/+ hearts) demonstrates that our cell sorting strategy enriched for distinct cell populations (EPDCs vs epicardial cells) and highlights differences in gene expression between these populations. Our immunohistochemistry studies suggested that the fate of EPDCs in the atrioventricular junction region is distinct from the fate of EPDCs in ventricular myocardium. To further investigate this point, we isolated EPDCs from the atrioventricular junction (AF EPDCs) and from the heart apex (Apex EPDCs) by FACS at E15.5 (Wt1 EPDCs showed that these cell populations express distinct gene programs (Fig. 8) . AF EPDCs exhibited higher expression of mesenchymal genes Tnc, Ddr2, and Fn1, upregulation of fibrosis genes Postn and Col1a1, and upregulation of the matrix-degrading enzyme Mmp2. EMT-related transcription factors were differentially expressed between AF and apex EPDCs, with AF EPDCs expressing increased Slug and Smad1 (Fig. 7D ). The upregulation of Smad1 and Slug transcripts might play a major role in AF EMT. The above findings indicate that AF EPDCs are distinct from apex EPDCs and suggest that local signals at the atrioventricular junction influence EPDC differentiation into components of the annulus fibrosis.
Discussion
The regulated differentiation of EPDCs is essential to form the annulus fibrosis, a ring of fibrous tissue essential for sequential atrial and ventricular contraction. Abnormal development of the annulus fibrosis has been linked to the development of abnormal accessory atrioventricular connections, creating the substrate for reciprocating tachycardias such as those seen in the WPW syndrome . In this study, we used genetic lineage tracing to definitively show for the first time that EPDCs contribute to the mammalian annulus fibrosis. Our study indicates that EPDCs migrate into this region through a process of EMT, becoming located within the periostin + annulus fibrosis. These EPDCs differentiate into fibroblasts and actively contribute to the synthesis of this structure, thereby electrically separating the atria and ventricles. Furthermore, our studies of AF EPDC gene expression demonstrate for the first time that EPDCs in the atrioventricular junction undergo a distinct differentiation program from myocardial EPDCs, suggesting that local signals at the atrioventricular junction direct AF EPDC differentiation.
The molecular regulators that govern EMT of epicardial cells for making AF EPDCs are poorly understood. We found that AF EPDCs are highly enriched in transcripts for EMT regulators Snail, Slug, Smad1, and Twist1 compared with non-EPDCs. Upregulation of these genes is also observed in other contexts associated with EMT (Mani et al., 2008) . Interestingly, epicardial cells also exhibited upregulation of Smad1 and Slug, but not Snail or Twist1. This suggests that upregulation of Snail or Twist1 may trigger the EMT process to form EPDCs from epicardial cells.
Epicardial cells undergo EMT throughout the myocardium to form EPDCs. However, our data indicate that there are regional differences in EPDC fate, perhaps as a result of local cues in the atrioventricular junction region. EPDCs were previously reported to differentiate into smooth muscle, endothelial, interstitial cell, and cardiomyocyte fates (Perez-Pomares et al., 2002; Wilm et al., 2005; Cai et al., 2008; Zhou et al., 2008a) . By immunohistochemistry, we did not find contribution of EPDCs to the cardiomyocyte lineage in the atrioventricular junction region, and EPDC differentiation to endothelial cells was also low in this region (Figs. 3D and 4C, and data not shown) . Differences between AF EPDC and apex EPDC fate were further supported by qRT-PCR, which revealed that fibrosis-related extracellular matrix genes were strongly upregulated in AF EPDCs. Most striking was the upregulation of periostin in AF EPDCs. This result was corroborated by immunohistochemistry, which likewise demonstrated strong periostin expression restricted to the atrioventricular junction region. Interestingly, the EMT regulators Slug and Smad1 were expressed at higher levels in AF compared to apical EPDCs. This observation suggests that distinct molecular pathways regulate the EMT process in epicardium at the atrioventricular junction versus the myocardial apex and leads us to hypothesize that Slug and Smad1 play important roles in the differentiation of this cell population.
One regional cue that might influence local EPDC fate is periostin, secreted at high levels in endocardial cushions and by EPDCs in the AF region Norris et al., 2008; Snider et al., 2008 ). Periostin appears to suppress myogenic fates of epicardial cells and endocardial cushion mesenchyme, as the expression of an Myh6-GFP transgene was ectopically activated in these locations in periostin null hearts (Norris et al., 2008; Snider et al., 2008) . Thus, periostin expressed by EPDCs and neighboring endocardial cushions may bias EPDC differentiation away from a myocyte fate and towards a fibroblast fate.
Migrating AF EPDCs may regulate formation of the annulus fibrosis by two mechanisms. First, EPDCs may differentiate into cells that directly contribute to synthesis of the annulus fibrosis. Our immunohistochemistry and gene expression studies definitively demonstrate that EPDCs contribute to the synthesis of the mammalian annulus fibrosis, including periostin and collagen I. Second, EPDCs may have an inductive role, stimulating other cells to differentiate into fibroblasts that contribute to synthesis of the annulus fibrosis. Consistent with these mechanisms, disruption of EPDC formation resulted in defective formation of the annulus fibrosis, producing accessory pathways that are the anatomical substrate for WPW (Kolditz et al., 2007; Kolditz et al., 2008) . The epicardium is a rich source of secreted factors, including Wnts (Zamora et al., 2007) , erythropoietin (Wu et al., 1999) , fibroblast growth factors (Lavine et al., 2005) , and retinoic acid (Merki et al., 2005) . In future work, it will be important to determine if these or other secreted factors play a selective role in directing formation of the annulus fibrosis.
Our study was based on the pulsed labeling of epicardially derived cells by an inducible Cre allele. While the pulse labeling strategy enhances specificity of labeling, it has some limitations. Most importantly, labeling of cells is incomplete, so that the extent of EPDC contribution to the annulus fibrosis is difficult to quantitate using the approach. Thus, partial labeling of periostin-expressing cells of the annulus fibrosis might be due to inefficient Cre labeling, which would lead to an underestimate of the contribution of EPDCs to the annulus fibrosis. Alternatively, unlabeled periostin-expressing cells of the annulus fibrosis might arise from a different source. Additional studies using additional Cre lines or alternative approaches will be required to distinguish these possibilities. However, this quantitative limitation does not undermine our conclusions on the fate of cells that are labeled by Cre. A second limitation is the inference that the pulselabeled cells arise from the epicardium. Based on our studies of Wt1 and CreERT2 expression in Wt1
CreERT2/+ hearts, we conclude that labeled cells within the myocardium arise by EMT of epicardial cells. This conclusion is well supported by independent methods in avian embryos Lie-Venema et al., 2008) , by dye labeling experiments in murine explant culture (Cai et al., 2008; Zhou et al., 2008a) , and by other Cre transgenes expressed in the epicardium (Merki et al., 2005; Cai et al., 2008) . However, we cannot formally exclude an alternative origin for the labeled cells.
In conclusion, our work advanced our understanding of annulus fibrosis development by definitively demonstrating the cellular contribution of EPDCs. Furthermore, we found that differentiation of EPDCs in the atrioventricular junction region is distinct from differentiation of EPDCs from the apical myocardium. These data suggest that local cues regulate EPDC differentiation.
